-6.1%
PATH vs THC
+238.5%
-244.6%
-65.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -16.6% | +0.6% | -17.2% | -16.7% |
| 7D | -16.3% | -0.7% | -15.7% | -16.2% |
| 30D | +9.9% | +1.3% | +8.6% | +9.5% |
| 3M | +30.2% | +64.2% | -34.1% | +17.5% |
| 6M | +37.2% | +8.3% | +28.9% | +34.6% |
| YTD | -7.3% | +33.4% | -40.7% | -14.1% |
| 1Y | +40.0% | +37.7% | +2.3% | +27.9% |
| All | -6.1% | +238.5% | -244.6% | -49.6% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling